Aberrant Lef1 expression has been widely associated with poor prognosis in leukemia [10,17] and several solid cancers such as colorectal [18,19], lung adenocarcinoma [12], and endometrial carcinoma [8]. This evidence concerns the gene LEF1 and endometrial carcinoma.